Improving quality of care and outcomes for heart failure: Role of registries

Circulation Journal

Volumn 75, Issue 8, 2011, Pages 1783-1790

  Fonarow, Gregg C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Follow up studies; Guidelines; Heart failure; Outcomes

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE PLUS ISOSORBIDE DINITRATE;

ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL INDICATOR; DECISION SUPPORT SYSTEM; DEFIBRILLATOR; DISEASE REGISTRY; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MORTALITY; OUTPATIENT CARE; PATIENT EDUCATION; PERFORMANCE MEASUREMENT SYSTEM; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; REVIEW; TOTAL QUALITY MANAGEMENT; UNITED STATES;

HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REGISTRIES; UNITED STATES;

EID: 79960786701     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0582     Document Type: Review

References (28)

1. Lloyd-Jones D, Adams R, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics: 2010 update: A report from the American Heart Association. Circulation 2010; 121: e46-e215.
2. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30-41.
3. Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 2005; 353: 255-264.
4. Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: Analysis of the ADHERE Registry. Arch Intern Med 2005; 165: 1469-1477.
5. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 2005; 294: 1240-1247.
6. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gattis Stough W, Gheorghiade M, et al. Heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. Circ Heart Fail 2008; 1: 98-106.
7. Albert NM, Yancy CW, Liang L, Zhao X, Hernandez AF, Peterson ED, et al. Use of aldosterone antagonists in heart failure. JAMA 2009; 302: 1658-1665.
8. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008; 118: 926-933.
9. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005; 112: e154-e235.
10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/ AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: e391-e479.
11. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819.
12. Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): Rationale and design. Am Heart J 2004; 148: 43-51.
13. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gattis Stough W, Gheorghiade M, et al. Improving the use of evidence-based heart failure therapies in the outpatient setting: The IMPROVE HF performance improvement registry. Am Heart J 2007; 154: 12-38.
14. Heidenreich PA, Lewis WR, LaBresh KA, Schwamm LH, Fonarow GC. Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure. Am Heart J 2009; 158: 546-553.
15. Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, et al. Influence of a performanceimprovement initiative on quality of care for patients hospitalized with heart failure: Results of the Organized Program to InitiateLifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med 2007; 167: 1493-1502.
16. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States (2001-2003): Rationale, design and preliminary observations from the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 49: 209-216.
17. Heidenreich PA, Fonarow GC. Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts. Am Heart J 2006; 152: 935-939.
18. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: Findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007; 153: 1021-1028.
19. Thomas KL, Hernandez AF, Dai D, Heidenreich P, Fonarow GC, Peterson ED, et al. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. Am Heart J 2011; 161: 746-754.
20. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the Registry to Improve the Use of Evidence-based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation 2010; 122: 585-596.
21. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, et al. Associations between outpatient heart failure processof-care measures and mortality. Circulation 2011; 123: 1601-1610.
22. Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, et al. The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: A policy statement from the American Heart Association. Circulation 2011; 123: 2167-2179.
23. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al; CHART Investigators. Analysis of chronic heart failure registry in the Tohoku district: Third year follow-up. Circ J 2004; 68: 427-434.
24. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H, on behalf of the CHART-2 Investigators. Trend for Westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 Study. Circ J 2011; 75: 823-833.
25. Hamaguchi S, Yokoshiki H, Kinugawa S, Tsuchihashi-Makaya M, Yokota T, Takeshita A, et al. Effects of atrial fibrillation on longterm outcomes in patients hospitalized for heart failure in Japan: A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 2084-2090.
26. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Yokota T, Takeshita A, Yokoshiki H, et al. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan: A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1901-1908.
27. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Yokota T, Goto K, et al. Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 2010; 74: 2605-2611.
28. Tsuchihashi-Makaya M, Kinugawa S, Yokoshiki H, Hamaguchi S, Yokota T, Goto D, et al. Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival. Circ J 2010; 74: 1364-1371.